(1) Test sites that may receive access to data in the prescription monitoring program under RCW 70.225.040 must be:
(a) Licensed by the department as a test site under chapter 70.42 RCW; and
(b) Certified as a drug testing laboratory by the United States department of health and human services, substance abuse and mental health services administration.
(2) Test sites may not:
(a) Charge a fee for accessing the prescription monitoring program;
(b) Store data accessed from the prescription drug monitoring program in any form, including, but not limited to, hard copies, electronic copies, or web/digital based copies of any kind. Such data may be used only to transmit to those entities listed in *RCW 70.255.040(3)(a).